Lineage Cell Therapeutics Inc (LCTX)
1.17
-0.01
(-0.85%)
USD |
NYAM |
May 10, 16:00
1.17
0.00 (0.00%)
After-Hours: 19:56
Lineage Cell Therapeutics 1 Year Total Returns (Daily): -19.73% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 09, 2024 | -19.73% |
May 08, 2024 | -22.15% |
May 07, 2024 | -11.89% |
May 06, 2024 | -9.09% |
May 03, 2024 | -27.40% |
May 02, 2024 | -22.79% |
May 01, 2024 | -13.74% |
April 30, 2024 | -19.85% |
April 29, 2024 | -17.65% |
April 26, 2024 | -15.56% |
April 25, 2024 | -15.91% |
April 24, 2024 | -20.29% |
April 23, 2024 | -14.93% |
April 22, 2024 | -14.93% |
April 19, 2024 | -16.06% |
April 18, 2024 | -13.67% |
April 17, 2024 | -5.84% |
April 16, 2024 | -18.44% |
April 15, 2024 | -11.35% |
April 12, 2024 | -7.14% |
April 11, 2024 | 1.44% |
April 10, 2024 | -3.57% |
April 09, 2024 | 2.19% |
April 08, 2024 | 7.30% |
April 05, 2024 | 1.45% |
Date | Value |
---|---|
April 04, 2024 | -1.37% |
April 03, 2024 | -10.53% |
April 02, 2024 | -6.67% |
April 01, 2024 | -2.67% |
March 28, 2024 | 8.03% |
March 27, 2024 | 0.72% |
March 26, 2024 | -10.27% |
March 25, 2024 | -12.33% |
March 22, 2024 | -7.30% |
March 21, 2024 | -2.16% |
March 20, 2024 | -11.59% |
March 19, 2024 | -14.18% |
March 18, 2024 | -17.02% |
March 15, 2024 | -4.44% |
March 14, 2024 | -16.55% |
March 13, 2024 | -14.79% |
March 12, 2024 | -13.29% |
March 11, 2024 | -9.79% |
March 08, 2024 | -10.96% |
March 07, 2024 | -17.52% |
March 06, 2024 | -18.12% |
March 05, 2024 | -22.86% |
March 04, 2024 | -18.57% |
March 01, 2024 | -19.57% |
February 29, 2024 | -22.96% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.20%
Minimum
Sep 04 2019
294.9%
Maximum
Mar 18 2021
14.51%
Average
-13.59%
Median
Dec 26 2019
1 Year Total Returns (Daily) Benchmarks
Acumen Pharmaceuticals Inc | -37.87% |
Sarepta Therapeutics Inc | 5.53% |
CEL-SCI Corp | -41.92% |
AIM ImmunoTech Inc | -10.90% |
IGC Pharma Inc | 48.57% |